{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-22-000009","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2022-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.316184+00:00","generated_at":"2026-06-24T22:12:04.524369+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Kewaunee Q4 sales up 28.4% to $49.7M; backlog record $173.9M; full year loss widens","bullets":["Q4 sales $49.7M (+28.4% YoY); pre-tax earnings $2.3M vs loss $0.95M; EBITDA $2.97M vs -$0.30M.","Diluted EPS -$0.13 vs -$1.08; net loss $0.36M includes $2.56M valuation allowance from sale-leaseback.","Full year sales $168.9M (+14.5%); net loss $6.1M vs $3.7M; diluted EPS -$2.20 vs -$1.33.","Backlog $173.9M, highest in company history; up from $114.5M a year ago.","Domestic segment Q4 net earnings $2.38M vs loss; International net income $1.02M vs $0.96M."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-22-000009","json":"https://secwatch.observer/filing/0000055529-22-000009.json","markdown":"https://secwatch.observer/filing/0000055529-22-000009.md","text":"https://secwatch.observer/filing/0000055529-22-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552922000009/0000055529-22-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552922000009/kequ-20220629.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T22:12:04.524369+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}